Topic

Jeff Legos

1 recent story · updated continuously

Businesswire

Pfizer's BRAFTOVI Regimen Shows Significant Survival Benefits in Metastatic Colorectal Cancer

healthJust now
Pfizer's BRAFTOVI Regimen Shows Significant Survival Benefits in Metastatic Colorectal Cancer